Cannabidiol
IRB00204427
Phase 2 small_molecule completed
Quick answer
Cannabidiol for Sturge-Weber Syndrome is a Phase 2 program (small_molecule) at Jazz Pharmaceuticals plc with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Jazz Pharmaceuticals plc
- Indication
- Sturge-Weber Syndrome
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed